ENAC

Main information

  • Trade name:
  • ENAC 30G GEL EXCEL
  • Dosage:
  • 1.16,3,10,5,1;%/W/W
  • Pharmaceutical form:
  • GEL EXCEL
  • Composition:
  • 30G
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ENAC 30G GEL EXCEL
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

11-7-2018

MyNicNaxs, LLC Issues Voluntary Nationwide Recall of Various Dietary Supplements Due to Undeclared Active Pharmaceutical Ingredient (API)

MyNicNaxs, LLC Issues Voluntary Nationwide Recall of Various Dietary Supplements Due to Undeclared Active Pharmaceutical Ingredient (API)

MyNicNaxs, LLC, Deltona, FL is voluntarily recalling all lots of dietary supplements distributed nationwide to the consumer level. The products have been found to contain undeclared active pharmaceutical ingredients (API). The presence of Sildenafil, Sibutramine, Diclofenac and/or Phenolphthalein in the dietary supplements renders it an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall. These products were distributed from January 2013, to December ...

FDA - U.S. Food and Drug Administration

29-6-2018

EU/3/18/2029 (Klinikum der UniversitAt MUnchen)

EU/3/18/2029 (Klinikum der UniversitAt MUnchen)

EU/3/18/2029 (Active substance: 2-[(2S)-2-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]-8-nitro-6-trifluoromethyl-4H-1,3-benzothiazin-4-one) - Orphan designation - Commission Decision (2018)4174 of Fri, 29 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/004/18

Europe -DG Health and Food Safety